THE NEXT GENERATION OF IMMUNOASSAYS
BLISA™
A proprietary bead-based platform enabling rapid, quantitative, and highly multiplexed immunoassays that empower scientists and organizations to make informed decisions with confidence.
Why BLISA™?
Rapid
Results in as little as 15 minutes.
Quantitative
Accurate, reproducible quantitative results.
Highly Multiplexed
Simultaneously detect dozens to hundreds of targets.
Low Sample Volume
As little as 20-50 uL of sample.
High Specificity
Engineered for exceptional sensitivity and specificity.
Automation Ready
Designed for high-throughput and seamless workflow.
Beyond BLISA™
Scientific & Technical Capabilities
Comprehensive expertise in assay development, multiplex immunoassays, biomarker analysis, automation, microfluidics, image analysis, and data science.
Scientific Collaboration & Custom Development
Partner with government agencies, academic laboratories, and industry to develop customized assays, validate new applications, and accelerate translation.
HelixShield™
Advanced molecular authentication and information protection technologies for secure digital and physical ecosystems.
Let’s advance
science together.
Partner with High Throughput Biology to develop innovative solutions that drive meaningful impact.
